Uniphar plc (AIM:UPR)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 909.85M |
| Revenue (ttm) | 2.48B |
| Net Income (ttm) | 56.84M |
| Shares Out | n/a |
| EPS (ttm) | 0.21 |
| PE Ratio | 16.01 |
| Forward PE | 16.63 |
| Dividend | 0.02 (0.00%) |
| Ex-Dividend Date | Apr 24, 2025 |
| Volume | 4,864 |
| Average Volume | 86,156 |
| Open | 346.25 |
| Previous Close | 347.00 |
| Day's Range | 346.25 - 346.25 |
| 52-Week Range | 163.00 - 368.00 |
| Beta | n/a |
| RSI | 55.08 |
| Earnings Date | Sep 2, 2025 |
About Uniphar
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source throug... [Read more]
Financial Performance
In 2024, Uniphar's revenue was 2.77 billion, an increase of 8.51% compared to the previous year's 2.55 billion. Earnings were 64.20 million, an increase of 43.26%.
Financial numbers in EUR Financial StatementsNews
Uniphar sees profits rise to 38m as growth accelerates
Operating profits at stock market-listed healthcare services firm Uniphar rose 5.6pc to 38.5m in the first half of the year.
Uniphar PLC (DUB:UPR) Q2 2025 Earnings Report Preview: What To Look For
Uniphar PLC (DUB:UPR) Q2 2025 Earnings Report Preview: What To Look For
The week ahead in business: Unemployment data, flash estimate on inflation and a host of trading updates
September is here and it is straight down to business with results and trading updates due from Kainos on Monday, Uniphar on Tuesday, Cairn Homes on Wednesday and Grafton Group.
Uniphar flags profit growth for first half of the year
Irish healthcare group Uniphar says the business achieved double-digit adjusted earnings per share growth in the first half of 2025, with 8pc organic gross profit growth and lower finance costs.
Uniphar agrees to undertakings pending injunction hearing over alleged breach of agreement
Dublin-based Thera seeks orders preventing Uniphar from blocking its trading account
Pharmacy brokerage Thera claims Uniphar breaching agreement in takeover bid
A pharmacy brokerage business has claimed in the High Court that pharma giant Uniphar is breaching an agreement in an attempted takeover bid and abusing its dominant position in the market.
Pharmacy broker claims Uniphar breaching agreement in attempted takeover
Company is seeking orders preventing blocking of trading account
Shares in Uniphar up more than 6pc after results
Shares in healthcare service company Uniphar are up more than 6pc after it announced bigger than expected profits and revenue for last year.
The week ahead in business: Bank of Ireland, Uniphar and Glanbia to announce results
Bank of Ireland will announce its full-year results for 2024 today.
Uniphar reports 8pc increase in profits last year
Healthcare service company Uniphar saw an 8pc growth in profits over the last financial year.
Uniphar reports increase in profits and revenues in first half of 2024
Irish healthcare services business Uniphar reported a rise in profits in the first six months of the year.